Drug shortages homepage
Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.
Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.
The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.
Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.
If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.
Below are the newest shortage and discontinuation reports and updates to existing ones.

LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
TARO-RAMIPRIL | SUN PHARMA CANADA INC | Actual shortage | 10MG | Updated Report | 2025-07-19 | 263203 |
TARO-PHENYTOIN | TARO PHARMACEUTICALS INC | Actual shortage | 125MG | Updated Report | 2025-07-19 | 262087 |
RAPAMUNE | PFIZER CANADA ULC | Resolved | 1MG | Updated Report | 2025-07-19 | 262711 |
TARO-EZETIMIBE | SUN PHARMA CANADA INC | Actual shortage | 10MG | Updated Report | 2025-07-19 | 263188 |
TARO-RAMIPRIL | SUN PHARMA CANADA INC | Actual shortage | 5MG | Updated Report | 2025-07-19 | 263200 |
EFUDEX | BAUSCH HEALTH, CANADA INC. | Resolved | 5% | Updated Report | 2025-07-19 | 262320 |
MYLAN-NAPROXEN/ESOMEPRAZOLE MR | MYLAN PHARMACEUTICALS ULC | Actual shortage | 20MG 500MG | Updated Report | 2025-07-19 | 262910 |
ALYSENA 21 | APOTEX INC | Actual shortage | 100MCG 20MCG | Updated Report | 2025-07-18 | 261623 |
APO-RISPERIDONE | APOTEX INC | Resolved | 0.50MG | Updated Report | 2025-07-18 | 258827 |
APO-LEVOTHYROXINE | APOTEX INC | Resolved | 200MCG | Updated Report | 2025-07-18 | 257525 |
Discontinuation Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
ACULAR LS | ABBVIE CORPORATION | Discontinued | 0.4% | Updated Report | 2025-07-19 | 248365 |
SELECT 1/35 (28-DAY) | PFIZER CANADA ULC | Discontinued | 0.035MG 1.0MG | Updated Report | 2025-07-11 | 259551 |
CODEINE 30 | LABORATOIRE RIVA INC. | To be discontinued | 30MG | New Report | 2025-07-10 | 262503 |
ZENHALE | ORGANON CANADA INC. | To be discontinued | 200MCG 5MCG | New Report | 2025-07-07 | 262162 |
ZENHALE | ORGANON CANADA INC. | To be discontinued | 5MCG 100MCG | New Report | 2025-07-07 | 262159 |